Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Maine Medicaid Waiver Qualifies For Rx Rebates By State Contributions – Court

Executive Summary

Maine's Medicaid waiver program qualifies for manufacturer rebates because of the state's contribution to beneficiaries' prescription costs, the D.C. federal court decided Feb. 25

You may also be interested in...



Maine Medicaid Waiver Plan Is Not Approved By HHS, PhRMA Argues

PhRMA's case against Maine's Medicaid waiver program argues that the program, as currently operating, is not approved by HHS

Maine Medicaid Waiver Plan Is Not Approved By HHS, PhRMA Argues

PhRMA's case against Maine's Medicaid waiver program argues that the program, as currently operating, is not approved by HHS

PhRMA v. Thompson

Washington, D.C. appeals court is scheduled to hear oral arguments in the Pharmaceutical Research & Manufacturers of America's case against HHS' approval of the Healthy Maine Prescription demonstration program Dec. 5. The D.C. federal court ruled that the program qualifies for manufacturer rebates (1'The Pink Sheet" March 4, p. 13)...

Related Content

UsernamePublicRestriction

Register

PS039405

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel